|
Essex in the News
Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA® more
Bankers Trust and American Express Officer George Carmany Joins
EWHV as Senior Advisor more
Genentech Uses Complete Genomics' Human Genome Sequencing Service to Compare Tumor and Normal Genome more more
EWHV Partners with Dan Lemaitre to Target Growth Equity Investments in Medical Devices more
Essex Woodlands Invests in ikaSystems, Supports Rapid Growth more
Health Care VCs Navigating Risks to Target Growth-Equity Investments more
Essex Woodlands Health Ventures Raises $900 Million Healthcare Fund more
Light Sciences Oncology Elects Former FDA Commissioner Frank Young, MD, PhD to Board of Directors more
EWHV Featured
in Wall Street Journal: Venture Firms Seek to Retain Younger Hires more
EWHV Expands Global Pharmaceutical Team: Former Pfizer Senior VP
Lisa Ricciardi Joins as Adjunct Partner (pdf)
more
Essex Woodlands Health Ventures Expands Top Tier Investment Team;
ex-Pfizer Human Health President Karen Katen Joins as Senior Advisor (pdf)
more
Essex
Woodlands Throws Its Weight Around (pdf)
more
Europe's
New Spec Pharma Models (pdf)
more
Essex
Woodlands Health Ventures Further Expands Global Investment Team; Steve
Wiggins Joins as Operating Partner (pdf)
more
Essex
Woodlands Significantly Expands Reach to Support New Fund (pdf) more
Essex
Woodlands Closes $600M in a Flash
more
The University of Chicago's Graduate School of Business Honors Immanuel
Thangaraj with a 2003 Distinguished Young Alumni Achievement Award
more
The Venture Capital Analyst: Essex Woodlands Caps Fund VI at $400
Million
more
Levering the Leavings: Specialty Pharmaceuticals Surge; Selling Drugs
the Big Businesses Forsake
more
Essex Woodlands Takes a Centrist Approach
more
Specialty Pharmaceutical Ventures, Popular Again, Face Fresh Obstacles
more
MicroMed Technology, Inc. Announces Closing of $23 Million Series "D"
Financing
more
Confluent Surgical, Inc. Raises $20 Million in Series-C financing
more |
